Conferences Artios Pharma is attending in 2026
Artios Pharma is listed at 2 conferences on Tnuki's calendar in 2026: ENA 2026 (on the program) and ELRIG Drug Discovery 2026 (on the program). Small-molecule drug discovery company developing targeted cancer therapies, including drugs that exploit DNA damage response pathways. As of Oct 17, 2026.
| Conference | Details | Involvement | Tnuki guide |
|---|---|---|---|
38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer TherapeuticsCancer drug discovery & early-development scientistsOfficial site |
Barcelona, Spain ~1.5k attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 1 poster Attendee mix: Mostly biopharma; preclinical and translational oncology scientists, phase I investigators and chemists, some academics
Attending
|
Open the guide Search and filter attendees |
ELRIG Drug Discovery 2026UK & European drug discovery scientistsOfficial site |
Past London, UK ~3k attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 1 talk Attendee mix: Mostly industry; UK and European pharma, biotech and CRO scientists, lab heads, screening and automation groups, some academics
Attending
|
Open the guide Search and filter attendees |
We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows Artios Pharma’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.
Instantly find decision makers at Artios Pharma
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!